4.6 Article

Cutting edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B

Journal

JOURNAL OF IMMUNOLOGY
Volume 178, Issue 1, Pages 33-37

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.178.1.33

Keywords

-

Categories

Funding

  1. Medical Research Council [MC_U137884180, G0200585] Funding Source: Medline
  2. NCI NIH HHS [N01-CO-12400] Funding Source: Medline
  3. NATIONAL CANCER INSTITUTE [Z01BC010791] Funding Source: NIH RePORTER
  4. MRC [G0200585, MC_U137884180] Funding Source: UKRI

Ask authors/readers for more resources

Although it is clear that KIR3DL1 recognizes Bw4(+) HLA-B, the role of Bw4(+) HLA-A allotypes as KIR3DL1 ligands is controversial We therefore examined the hinding of tetrameric HLA-A and -B complexes, including HLA*2402, a common Bw4(+) HLA-A allotype, to KIR3DLI*001, *005, *007, and *1502 allotypes. Only Bw4(+) tetramers hound K7R3DL1. Three of four HLA-A*2402 tetramers bound one or more KIR3DL1 allotypes and all four KIR3DL1 allotypes bound to one or more HLA-A*2402 tetramers, but with different binding specificities. Only KTR3DL1*005 bound both HLA-A*2402 and HLA-B*5703 tetramers. HLA-A*2402-expressing target cells were resistant to lysis by NK cells expressing KIR3DL1*001 or *005. This study shows that HLA-A*2402 is a ligand for KIR3DL1 and demonstrates how the binding of KIR3DL1 to Bw4(+) ligands depends upon the bound peptide as well as HLA and KIR3DL1 polymorphism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available